Myomo (MYO) Shares Outstanding (2016 - 2025)
Myomo's (MYO) quarterly Shares Outstanding (Entity) came in at $38.5 million in Q4 2025, up 11.91% YoY from $34.4 million in Q4 2024, and little changed on a QoQ basis from $38.4 million in Q3 2025.
Myomo (MYO) Shares Outstanding (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Shares Outstanding (Entity) data on file, last reported at $38.5 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 11.91% year-over-year to $38.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $38.5 million (up 11.91% YoY) and the FY2025 annual result came in at $38.5 million, up 11.91% from the prior year.
- Shares Outstanding (Entity) was little changed at $38.5 million in Q4 2025, from $38.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $38.5 million in Q4 2025 to a low of $5.6 million in Q1 2021.
- A 5-year average of $22.6 million and a median of $27.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 400.02% — and 2025, when it fell 6.3%.
- Tracing MYO's Shares Outstanding (Entity) over 5 years: stood at $6.9 million in 2021, then climbed by 12.82% to $7.8 million in 2022, then surged by 250.1% to $27.1 million in 2023, then increased by 26.69% to $34.4 million in 2024, then grew by 11.91% to $38.5 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $38.5 million (Q4 2025), $38.4 million (Q3 2025), and $37.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Myomo | 72.95 Mn | 53.98 Mn | - | 42.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.17 Mn |
| Sep 30, 2025 | 42.17 Mn |
| Jun 30, 2025 | 41.58 Mn |
| Mar 31, 2025 | 41.45 Mn |
| Dec 31, 2024 | 37.76 Mn |
| Sep 30, 2024 | 37.95 Mn |
| Jun 30, 2024 | 37.37 Mn |
| Mar 31, 2024 | 36.75 Mn |
| Dec 31, 2023 | 29.50 Mn |
| Sep 30, 2023 | 35.27 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 24.20 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 6.92 Mn |
| Mar 31, 2022 | 6.89 Mn |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | 5.68 Mn |
| Jun 30, 2021 | 5.64 Mn |
| Mar 31, 2021 | 5.19 Mn |